WFA
WestHill Financial Advisors Portfolio holdings
AUM
$471M
This Quarter Return
-0.54%
1 Year Return
+12.21%
3 Year Return
+45.56%
5 Year Return
–
10 Year Return
–
AUM
$446M
AUM Growth
+$446M
(+0.13%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
80.97%
Holding
80
New
5
Increased
27
Reduced
24
Closed
2
Top Buys
| 1 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
$11.3M |
| 2 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
$5.24M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$1.43M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$1.28M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
$1.26M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$275K |
| 2 |
Merck
MRK
|
$245K |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
$229K |
| 4 |
Nike
NKE
|
$201K |
| 5 |
Nurix Therapeutics
NRIX
|
$188K |
Sector Composition
| 1 | Technology | 4.21% |
| 2 | Healthcare | 1.47% |
| 3 | Financials | 0.75% |
| 4 | Consumer Discretionary | 0.55% |
| 5 | Consumer Staples | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Invesco California Value Municipal Income Trust
VCV
$490M
| $130K | 0.03% |
11,925
| – | – |
|
|
GGN
77
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$742M
| $45.6K | 0.01% |
12,100
| – | – |
|
78
CytomX Therapeutics
CTMX
$343M
| $17.6K | ﹤0.01% |
17,082
| – | – |
|
|
79
Merck
MRK
$214B
| – | – |
-2,160
| Closed | -$245K |
|
|
80
Nike
NKE
$110B
| – | – |
-2,272
| Closed | -$201K |
|